Suven Pharmaceuticals Shows Strong Performance Amid Broader Market Gains - MarketsMojo
Yesterday • Google News
Suven Life Sciences Limited (SUVEN)
NSEINR 1261.57%
Price Chart
Key Statistics
Market Cap
INR 27.05B
P/E Ratio
0.00
Revenue (TTM)
INR 75.74M
Volume
288.88K
52W High
INR 169.30
52W Low
INR 82.95
Dividend Yield
0.00%
Beta
1.78
Technicals
50-Day MA
121.8798
200-Day MA
130.2105
52 Week High
169.3
52 Week Low
82.95
About SUVEN
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative dis.
Employees
141
Headquarters
Hyderabad, India
CEO
Mr. Venkateswarlu Jasti M.Pharm. M.S.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg